Prophylactic recombinant human granulocyte/granulocyte-macrophage colony-stimulating factor in children with hematologic malignancies after chemotherapy
Objective: To analyze the efficacy and adverse effects of post-chemotherapy prophylactic recombinant human granulocyte/granulocyte-macrophage colony-stimulating factor(rhG/GM-CSF) in children with hematologic malignancies.Methods: The time of neutrophil recovery and the incidence rates of infection and adverse events of prophylactic use of rhG/GM-CSF within 24-48 h after chemotherapy in children with high-risk acute lymphoblastic leukemia/lymphoblastic lymphoma(HR-ALL/LBL), acute myeloid leukemia(AML) or B-...